Related Experiment Video
Updated: Jun 23, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
[Cell therapy for acute myocardial infarction].
1Inserm, UMR915, Faculté de Médecine,Institut du Thorax, 44000 Nantes, France. patricia.lemarchand@univ-nantes.fr
Bone marrow stem cell therapy shows potential for repairing heart tissue after acute myocardial infarction (AMI). While early trials suggest safety and improved cardiac function, further large-scale studies are needed to confirm efficacy.
Area of Science:
- Cardiology
- Regenerative Medicine
- Stem Cell Biology
Context:
- Acute myocardial infarction (AMI) significantly contributes to heart failure and mortality.
- Limited natural regeneration capacity of injured cardiac tissue necessitates therapeutic interventions.
- Bone marrow stem/progenitor cells are investigated for their potential to repair vascular and cardiac damage post-AMI.
Purpose:
- To review the progress and outcomes of stem cell therapy for acute myocardial infarction (AMI).
- To evaluate the safety and efficacy of bone marrow stem/progenitor cell administration following AMI.
- To identify the need for further large-scale clinical trials to establish the therapeutic benefits of cardiac cell therapy.
Summary:
- Initial Phase I clinical trials (2002-2004) indicated safety and promising improvements in clinical outcomes and cardiac function after AMI with stem cell therapy.
- Recent randomized controlled trials have yielded mixed results.
- A meta-analysis of 13 trials (811 participants) demonstrated a modest 2.99% improvement in left ventricular ejection fraction.
Impact:
- Stem cell therapy represents a promising avenue for treating AMI, potentially reducing heart failure and mortality.
- Current evidence suggests a need for larger, multicenter international trials to definitively establish the clinical efficacy of cardiac cell therapy.
- Further research is crucial to optimize cell types, delivery methods, and patient selection for maximizing therapeutic benefits in AMI patients.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Myocarditis III: Medical Management
Acute Coronary Syndrome I: Introduction
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Myocarditis I: Introduction
Acute Coronary Syndrome V: Nursing Management

